About - CBLL :

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Employees - 281, CEO - Dr. Xingjuan Chao Ph.D., Sector - Healthcare, Country - US, Market Cap - 532.47M

- Current Price $14.85 - Analyst Target Price $33.00

Stats & Key Metrics
TickerCBLL
IndexRUT
Curent Price 14.85
Change2.45%
Market Cap532.47M
Average Volume242.73K
Income-
Sales-
Book Value/Share5.33
Cash/Share5.42
Dividend Est-
Dividend TTM-
Dividend Ex-Date-
Employees281
Moving Avg 20days-16.18%
Moving Avg 50days-27.95%
Moving Avg 200days-37.71%
Shares Outstanding35.85M
Earnings DateFeb 25 AMC
Inst. Ownership46.11%
Key Ratios & Margins
Price/Earnings-
Forwad P/E-
PE Growth-
Price/Sales-
Price/Book2.78
Price/Cash2.74
Price/FCF-
Quick Ratio16.05
Current Ratio16.59
Debt/Equity0.11
Return on Assets-
Return on Equity-
Return on Investment-
Gross Margin-
Ops Margin-
Profit Margin-
RSI38.65
BETA(β)-
From 52week Low48.30%
From 52week High-54.67%
Earnings & Valuation
EPS-
EPS next Year-1.34
EPS next Qtr-0.41
EPS this Year52.00%
EPS next 5 Year35.69%
EPS past 5 Year-
Sales past 5 Year59.59%
EPS Y/Y-
Sales Y/Y-
EPS Q/Q-
Sales Q/Q-
Sales Surprise5.59%
EPS Surprise-25.79%
ATR(14)1.82
Perf Week33.14%
Perf Month-28.06%
Perf Quarter-26.33%
Perf Year-
Perf YTD-42.64%
Target Price33.00

AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer